nodes	percent_of_prediction	percent_of_DWPC	metapath
Enzalutamide—AR—Ergocalciferol—osteoporosis	0.155	0.201	CbGbCtD
Enzalutamide—AR—Estradiol—osteoporosis	0.0805	0.104	CbGbCtD
Enzalutamide—ALB—Estropipate—osteoporosis	0.0549	0.0711	CbGbCtD
Enzalutamide—CYP2B6—Raloxifene—osteoporosis	0.0374	0.0484	CbGbCtD
Enzalutamide—CYP2B6—Ethinyl Estradiol—osteoporosis	0.0361	0.0468	CbGbCtD
Enzalutamide—CYP2C9—Estropipate—osteoporosis	0.0296	0.0383	CbGbCtD
Enzalutamide—CYP2B6—Cholecalciferol—osteoporosis	0.0288	0.0374	CbGbCtD
Enzalutamide—CYP2C8—Raloxifene—osteoporosis	0.0283	0.0367	CbGbCtD
Enzalutamide—CYP2C8—Ethinyl Estradiol—osteoporosis	0.0273	0.0354	CbGbCtD
Enzalutamide—ALB—Estradiol—osteoporosis	0.0228	0.0295	CbGbCtD
Enzalutamide—CYP2C8—Cholecalciferol—osteoporosis	0.0218	0.0283	CbGbCtD
Enzalutamide—ABCB1—Ethinyl Estradiol—osteoporosis	0.0185	0.024	CbGbCtD
Enzalutamide—CYP2C19—Cholecalciferol—osteoporosis	0.0183	0.0237	CbGbCtD
Enzalutamide—CYP3A5—Estradiol—osteoporosis	0.0183	0.0237	CbGbCtD
Enzalutamide—CYP2C8—Estradiol—osteoporosis	0.0176	0.0228	CbGbCtD
Enzalutamide—CYP3A4—Estropipate—osteoporosis	0.0172	0.0223	CbGbCtD
Enzalutamide—CYP3A4—Calcitriol—osteoporosis	0.0172	0.0223	CbGbCtD
Enzalutamide—CYP2C9—Cholecalciferol—osteoporosis	0.0152	0.0197	CbGbCtD
Enzalutamide—CYP2C19—Estradiol—osteoporosis	0.0148	0.0191	CbGbCtD
Enzalutamide—CYP2D6—Cholecalciferol—osteoporosis	0.0139	0.0181	CbGbCtD
Enzalutamide—CYP3A4—Ergocalciferol—osteoporosis	0.0137	0.0178	CbGbCtD
Enzalutamide—ABCB1—Conjugated Estrogens—osteoporosis	0.0136	0.0176	CbGbCtD
Enzalutamide—CYP2C9—Estradiol—osteoporosis	0.0123	0.0159	CbGbCtD
Enzalutamide—ABCB1—Estradiol—osteoporosis	0.0119	0.0154	CbGbCtD
Enzalutamide—CYP3A4—Raloxifene—osteoporosis	0.0115	0.0149	CbGbCtD
Enzalutamide—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0111	0.0144	CbGbCtD
Enzalutamide—CYP3A4—Cholecalciferol—osteoporosis	0.00886	0.0115	CbGbCtD
Enzalutamide—CYP3A4—Conjugated Estrogens—osteoporosis	0.00813	0.0105	CbGbCtD
Enzalutamide—CYP3A4—Estradiol—osteoporosis	0.00714	0.00925	CbGbCtD
Enzalutamide—Back pain—Ibandronate—osteoporosis	0.000546	0.00288	CcSEcCtD
Enzalutamide—Hypoaesthesia—Ethinyl Estradiol—osteoporosis	0.000546	0.00288	CcSEcCtD
Enzalutamide—Pharyngitis—Ethinyl Estradiol—osteoporosis	0.000544	0.00287	CcSEcCtD
Enzalutamide—Neutropenia—Zoledronate—osteoporosis	0.000542	0.00286	CcSEcCtD
Enzalutamide—Urinary tract disorder—Ethinyl Estradiol—osteoporosis	0.000542	0.00286	CcSEcCtD
Enzalutamide—Haematuria—Pamidronate—osteoporosis	0.00054	0.00285	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Zoledronate—osteoporosis	0.000539	0.00284	CcSEcCtD
Enzalutamide—Connective tissue disorder—Ethinyl Estradiol—osteoporosis	0.000539	0.00284	CcSEcCtD
Enzalutamide—Urethral disorder—Ethinyl Estradiol—osteoporosis	0.000538	0.00284	CcSEcCtD
Enzalutamide—Bronchitis—Conjugated Estrogens—osteoporosis	0.000537	0.00283	CcSEcCtD
Enzalutamide—Asthenia—Ergocalciferol—osteoporosis	0.000536	0.00283	CcSEcCtD
Enzalutamide—Rhinitis—Risedronate—osteoporosis	0.000536	0.00283	CcSEcCtD
Enzalutamide—Pollakiuria—Zoledronate—osteoporosis	0.000536	0.00283	CcSEcCtD
Enzalutamide—Sinusitis—Pamidronate—osteoporosis	0.000531	0.0028	CcSEcCtD
Enzalutamide—Pharyngitis—Risedronate—osteoporosis	0.000531	0.0028	CcSEcCtD
Enzalutamide—Vertigo—Estropipate—osteoporosis	0.000529	0.00279	CcSEcCtD
Enzalutamide—Urinary tract disorder—Risedronate—osteoporosis	0.000528	0.00279	CcSEcCtD
Enzalutamide—Oedema peripheral—Risedronate—osteoporosis	0.000527	0.00278	CcSEcCtD
Enzalutamide—Connective tissue disorder—Risedronate—osteoporosis	0.000525	0.00277	CcSEcCtD
Enzalutamide—Urethral disorder—Risedronate—osteoporosis	0.000524	0.00276	CcSEcCtD
Enzalutamide—Vertigo—Alendronate—osteoporosis	0.000521	0.00275	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Conjugated Estrogens—osteoporosis	0.000519	0.00274	CcSEcCtD
Enzalutamide—Infestation NOS—Zoledronate—osteoporosis	0.000517	0.00273	CcSEcCtD
Enzalutamide—Infestation—Zoledronate—osteoporosis	0.000517	0.00273	CcSEcCtD
Enzalutamide—Vertigo—Raloxifene—osteoporosis	0.000513	0.0027	CcSEcCtD
Enzalutamide—Rhinitis—Pamidronate—osteoporosis	0.00051	0.00269	CcSEcCtD
Enzalutamide—Vertigo—Ibandronate—osteoporosis	0.000507	0.00268	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Etidronic acid—osteoporosis	0.000506	0.00267	CcSEcCtD
Enzalutamide—Urinary tract disorder—Pamidronate—osteoporosis	0.000502	0.00265	CcSEcCtD
Enzalutamide—Arthralgia—Estropipate—osteoporosis	0.000501	0.00265	CcSEcCtD
Enzalutamide—Anxiety—Estropipate—osteoporosis	0.0005	0.00264	CcSEcCtD
Enzalutamide—Connective tissue disorder—Pamidronate—osteoporosis	0.000499	0.00263	CcSEcCtD
Enzalutamide—Paraesthesia—Etidronic acid—osteoporosis	0.000499	0.00263	CcSEcCtD
Enzalutamide—Urethral disorder—Pamidronate—osteoporosis	0.000498	0.00263	CcSEcCtD
Enzalutamide—Infestation NOS—Conjugated Estrogens—osteoporosis	0.000498	0.00263	CcSEcCtD
Enzalutamide—Infestation—Conjugated Estrogens—osteoporosis	0.000498	0.00263	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Estropipate—osteoporosis	0.000498	0.00263	CcSEcCtD
Enzalutamide—Angiopathy—Ethinyl Estradiol—osteoporosis	0.000498	0.00262	CcSEcCtD
Enzalutamide—Haematuria—Zoledronate—osteoporosis	0.000493	0.0026	CcSEcCtD
Enzalutamide—Hypertension—Ibandronate—osteoporosis	0.000488	0.00257	CcSEcCtD
Enzalutamide—Arthralgia—Raloxifene—osteoporosis	0.000486	0.00256	CcSEcCtD
Enzalutamide—Angiopathy—Risedronate—osteoporosis	0.000485	0.00256	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Raloxifene—osteoporosis	0.000482	0.00254	CcSEcCtD
Enzalutamide—Arthralgia—Ibandronate—osteoporosis	0.000481	0.00254	CcSEcCtD
Enzalutamide—Mental disorder—Ethinyl Estradiol—osteoporosis	0.00048	0.00253	CcSEcCtD
Enzalutamide—Anxiety—Ibandronate—osteoporosis	0.000479	0.00253	CcSEcCtD
Enzalutamide—Convulsion—Calcitriol—osteoporosis	0.000479	0.00253	CcSEcCtD
Enzalutamide—Infection—Estropipate—osteoporosis	0.000478	0.00252	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Ibandronate—osteoporosis	0.000478	0.00252	CcSEcCtD
Enzalutamide—Hypertension—Calcitriol—osteoporosis	0.000477	0.00252	CcSEcCtD
Enzalutamide—Dry skin—Estradiol—osteoporosis	0.000474	0.0025	CcSEcCtD
Enzalutamide—Nervous system disorder—Estropipate—osteoporosis	0.000471	0.00249	CcSEcCtD
Enzalutamide—Infection—Alendronate—osteoporosis	0.00047	0.00248	CcSEcCtD
Enzalutamide—Anxiety—Calcitriol—osteoporosis	0.000469	0.00247	CcSEcCtD
Enzalutamide—Mental disorder—Risedronate—osteoporosis	0.000468	0.00247	CcSEcCtD
Enzalutamide—Sinusitis—Conjugated Estrogens—osteoporosis	0.000467	0.00246	CcSEcCtD
Enzalutamide—Skin disorder—Estropipate—osteoporosis	0.000467	0.00246	CcSEcCtD
Enzalutamide—Infection—Raloxifene—osteoporosis	0.000463	0.00244	CcSEcCtD
Enzalutamide—Nasopharyngitis—Estradiol—osteoporosis	0.000462	0.00244	CcSEcCtD
Enzalutamide—Hypoaesthesia—Zoledronate—osteoporosis	0.000462	0.00244	CcSEcCtD
Enzalutamide—Back pain—Ethinyl Estradiol—osteoporosis	0.000462	0.00244	CcSEcCtD
Enzalutamide—Angiopathy—Pamidronate—osteoporosis	0.000461	0.00243	CcSEcCtD
Enzalutamide—Urinary tract disorder—Zoledronate—osteoporosis	0.000458	0.00242	CcSEcCtD
Enzalutamide—Infection—Ibandronate—osteoporosis	0.000458	0.00242	CcSEcCtD
Enzalutamide—Oedema peripheral—Zoledronate—osteoporosis	0.000457	0.00241	CcSEcCtD
Enzalutamide—Nervous system disorder—Raloxifene—osteoporosis	0.000457	0.00241	CcSEcCtD
Enzalutamide—Connective tissue disorder—Zoledronate—osteoporosis	0.000456	0.00241	CcSEcCtD
Enzalutamide—Thrombocytopenia—Raloxifene—osteoporosis	0.000456	0.0024	CcSEcCtD
Enzalutamide—Urethral disorder—Zoledronate—osteoporosis	0.000455	0.0024	CcSEcCtD
Enzalutamide—Skin disorder—Raloxifene—osteoporosis	0.000452	0.00239	CcSEcCtD
Enzalutamide—Nervous system disorder—Ibandronate—osteoporosis	0.000452	0.00238	CcSEcCtD
Enzalutamide—Back pain—Risedronate—osteoporosis	0.00045	0.00238	CcSEcCtD
Enzalutamide—Rhinitis—Conjugated Estrogens—osteoporosis	0.000448	0.00236	CcSEcCtD
Enzalutamide—Skin disorder—Ibandronate—osteoporosis	0.000448	0.00236	CcSEcCtD
Enzalutamide—Hypoaesthesia—Conjugated Estrogens—osteoporosis	0.000445	0.00235	CcSEcCtD
Enzalutamide—Pharyngitis—Conjugated Estrogens—osteoporosis	0.000444	0.00234	CcSEcCtD
Enzalutamide—Oedema peripheral—Conjugated Estrogens—osteoporosis	0.00044	0.00232	CcSEcCtD
Enzalutamide—Skin disorder—Calcitriol—osteoporosis	0.000438	0.00231	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Estropipate—osteoporosis	0.000438	0.00231	CcSEcCtD
Enzalutamide—Insomnia—Estropipate—osteoporosis	0.000435	0.00229	CcSEcCtD
Enzalutamide—Paraesthesia—Estropipate—osteoporosis	0.000432	0.00228	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Alendronate—osteoporosis	0.000431	0.00228	CcSEcCtD
Enzalutamide—Bronchitis—Estradiol—osteoporosis	0.00043	0.00227	CcSEcCtD
Enzalutamide—Back pain—Pamidronate—osteoporosis	0.000428	0.00226	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Raloxifene—osteoporosis	0.000424	0.00224	CcSEcCtD
Enzalutamide—Angiopathy—Zoledronate—osteoporosis	0.000421	0.00222	CcSEcCtD
Enzalutamide—Insomnia—Raloxifene—osteoporosis	0.000421	0.00222	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Ibandronate—osteoporosis	0.00042	0.00222	CcSEcCtD
Enzalutamide—Vertigo—Risedronate—osteoporosis	0.000418	0.00221	CcSEcCtD
Enzalutamide—Insomnia—Ibandronate—osteoporosis	0.000417	0.0022	CcSEcCtD
Enzalutamide—Upper respiratory tract infection—Estradiol—osteoporosis	0.000415	0.00219	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Estropipate—osteoporosis	0.000415	0.00219	CcSEcCtD
Enzalutamide—Fatigue—Estropipate—osteoporosis	0.000414	0.00219	CcSEcCtD
Enzalutamide—Paraesthesia—Ibandronate—osteoporosis	0.000414	0.00218	CcSEcCtD
Enzalutamide—Pollakiuria—Estradiol—osteoporosis	0.000413	0.00218	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Calcitriol—osteoporosis	0.000411	0.00217	CcSEcCtD
Enzalutamide—Insomnia—Calcitriol—osteoporosis	0.000408	0.00215	CcSEcCtD
Enzalutamide—Mental disorder—Zoledronate—osteoporosis	0.000407	0.00215	CcSEcCtD
Enzalutamide—Angiopathy—Conjugated Estrogens—osteoporosis	0.000406	0.00214	CcSEcCtD
Enzalutamide—Anxiety—Ethinyl Estradiol—osteoporosis	0.000405	0.00214	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000404	0.00213	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Raloxifene—osteoporosis	0.000402	0.00212	CcSEcCtD
Enzalutamide—Hypertension—Risedronate—osteoporosis	0.000402	0.00212	CcSEcCtD
Enzalutamide—Pneumonia—Estradiol—osteoporosis	0.000401	0.00211	CcSEcCtD
Enzalutamide—Infestation NOS—Estradiol—osteoporosis	0.000399	0.0021	CcSEcCtD
Enzalutamide—Infestation—Estradiol—osteoporosis	0.000399	0.0021	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000398	0.0021	CcSEcCtD
Enzalutamide—Fatigue—Ibandronate—osteoporosis	0.000397	0.0021	CcSEcCtD
Enzalutamide—Arthralgia—Risedronate—osteoporosis	0.000396	0.00209	CcSEcCtD
Enzalutamide—Leukopenia—Pamidronate—osteoporosis	0.000396	0.00209	CcSEcCtD
Enzalutamide—Anxiety—Risedronate—osteoporosis	0.000395	0.00208	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000394	0.00208	CcSEcCtD
Enzalutamide—Pruritus—Etidronic acid—osteoporosis	0.000393	0.00207	CcSEcCtD
Enzalutamide—Mental disorder—Conjugated Estrogens—osteoporosis	0.000392	0.00207	CcSEcCtD
Enzalutamide—Back pain—Zoledronate—osteoporosis	0.000391	0.00206	CcSEcCtD
Enzalutamide—Infection—Ethinyl Estradiol—osteoporosis	0.000387	0.00204	CcSEcCtD
Enzalutamide—Convulsion—Pamidronate—osteoporosis	0.000383	0.00202	CcSEcCtD
Enzalutamide—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000382	0.00202	CcSEcCtD
Enzalutamide—Hypertension—Pamidronate—osteoporosis	0.000382	0.00202	CcSEcCtD
Enzalutamide—Diarrhoea—Etidronic acid—osteoporosis	0.00038	0.00201	CcSEcCtD
Enzalutamide—Haematuria—Estradiol—osteoporosis	0.00038	0.002	CcSEcCtD
Enzalutamide—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000378	0.002	CcSEcCtD
Enzalutamide—Infection—Risedronate—osteoporosis	0.000377	0.00199	CcSEcCtD
Enzalutamide—Arthralgia—Pamidronate—osteoporosis	0.000377	0.00199	CcSEcCtD
Enzalutamide—Back pain—Conjugated Estrogens—osteoporosis	0.000376	0.00199	CcSEcCtD
Enzalutamide—Epistaxis—Estradiol—osteoporosis	0.000376	0.00198	CcSEcCtD
Enzalutamide—Anxiety—Pamidronate—osteoporosis	0.000375	0.00198	CcSEcCtD
Enzalutamide—Sinusitis—Estradiol—osteoporosis	0.000374	0.00197	CcSEcCtD
Enzalutamide—Nervous system disorder—Risedronate—osteoporosis	0.000373	0.00197	CcSEcCtD
Enzalutamide—Skin disorder—Risedronate—osteoporosis	0.000369	0.00195	CcSEcCtD
Enzalutamide—Vertigo—Zoledronate—osteoporosis	0.000363	0.00192	CcSEcCtD
Enzalutamide—Leukopenia—Zoledronate—osteoporosis	0.000362	0.00191	CcSEcCtD
Enzalutamide—Infection—Pamidronate—osteoporosis	0.000359	0.00189	CcSEcCtD
Enzalutamide—Rhinitis—Estradiol—osteoporosis	0.000359	0.00189	CcSEcCtD
Enzalutamide—Hypoaesthesia—Estradiol—osteoporosis	0.000356	0.00188	CcSEcCtD
Enzalutamide—Pharyngitis—Estradiol—osteoporosis	0.000355	0.00187	CcSEcCtD
Enzalutamide—Nervous system disorder—Pamidronate—osteoporosis	0.000354	0.00187	CcSEcCtD
Enzalutamide—Thrombocytopenia—Pamidronate—osteoporosis	0.000354	0.00187	CcSEcCtD
Enzalutamide—Urinary tract disorder—Estradiol—osteoporosis	0.000353	0.00186	CcSEcCtD
Enzalutamide—Oedema peripheral—Estradiol—osteoporosis	0.000352	0.00186	CcSEcCtD
Enzalutamide—Connective tissue disorder—Estradiol—osteoporosis	0.000352	0.00185	CcSEcCtD
Enzalutamide—Urethral disorder—Estradiol—osteoporosis	0.000351	0.00185	CcSEcCtD
Enzalutamide—Convulsion—Zoledronate—osteoporosis	0.00035	0.00185	CcSEcCtD
Enzalutamide—Vertigo—Conjugated Estrogens—osteoporosis	0.00035	0.00184	CcSEcCtD
Enzalutamide—Hypertension—Zoledronate—osteoporosis	0.000349	0.00184	CcSEcCtD
Enzalutamide—Headache—Etidronic acid—osteoporosis	0.000348	0.00184	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Risedronate—osteoporosis	0.000346	0.00183	CcSEcCtD
Enzalutamide—Asthenia—Estropipate—osteoporosis	0.000345	0.00182	CcSEcCtD
Enzalutamide—Arthralgia—Zoledronate—osteoporosis	0.000344	0.00182	CcSEcCtD
Enzalutamide—Insomnia—Risedronate—osteoporosis	0.000344	0.00181	CcSEcCtD
Enzalutamide—Anxiety—Zoledronate—osteoporosis	0.000343	0.00181	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000342	0.0018	CcSEcCtD
Enzalutamide—Paraesthesia—Risedronate—osteoporosis	0.000341	0.0018	CcSEcCtD
Enzalutamide—Pruritus—Estropipate—osteoporosis	0.00034	0.00179	CcSEcCtD
Enzalutamide—Asthenia—Alendronate—osteoporosis	0.00034	0.00179	CcSEcCtD
Enzalutamide—Convulsion—Conjugated Estrogens—osteoporosis	0.000337	0.00178	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000336	0.00177	CcSEcCtD
Enzalutamide—Fatigue—Ethinyl Estradiol—osteoporosis	0.000336	0.00177	CcSEcCtD
Enzalutamide—Pruritus—Alendronate—osteoporosis	0.000335	0.00177	CcSEcCtD
Enzalutamide—Arthralgia—Conjugated Estrogens—osteoporosis	0.000331	0.00175	CcSEcCtD
Enzalutamide—Asthenia—Ibandronate—osteoporosis	0.000331	0.00174	CcSEcCtD
Enzalutamide—Anxiety—Conjugated Estrogens—osteoporosis	0.00033	0.00174	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000329	0.00174	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000329	0.00174	CcSEcCtD
Enzalutamide—Diarrhoea—Estropipate—osteoporosis	0.000329	0.00173	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Risedronate—osteoporosis	0.000328	0.00173	CcSEcCtD
Enzalutamide—Infection—Zoledronate—osteoporosis	0.000328	0.00173	CcSEcCtD
Enzalutamide—Fatigue—Risedronate—osteoporosis	0.000327	0.00173	CcSEcCtD
Enzalutamide—Insomnia—Pamidronate—osteoporosis	0.000327	0.00172	CcSEcCtD
Enzalutamide—Pruritus—Ibandronate—osteoporosis	0.000326	0.00172	CcSEcCtD
Enzalutamide—Angiopathy—Estradiol—osteoporosis	0.000325	0.00171	CcSEcCtD
Enzalutamide—Paraesthesia—Pamidronate—osteoporosis	0.000324	0.00171	CcSEcCtD
Enzalutamide—Diarrhoea—Alendronate—osteoporosis	0.000324	0.00171	CcSEcCtD
Enzalutamide—Asthenia—Calcitriol—osteoporosis	0.000324	0.00171	CcSEcCtD
Enzalutamide—Nervous system disorder—Zoledronate—osteoporosis	0.000323	0.00171	CcSEcCtD
Enzalutamide—Thrombocytopenia—Zoledronate—osteoporosis	0.000323	0.0017	CcSEcCtD
Enzalutamide—Skin disorder—Zoledronate—osteoporosis	0.00032	0.00169	CcSEcCtD
Enzalutamide—Pruritus—Calcitriol—osteoporosis	0.000319	0.00168	CcSEcCtD
Enzalutamide—Diarrhoea—Raloxifene—osteoporosis	0.000319	0.00168	CcSEcCtD
Enzalutamide—Dizziness—Estropipate—osteoporosis	0.000318	0.00168	CcSEcCtD
Enzalutamide—Infection—Conjugated Estrogens—osteoporosis	0.000316	0.00166	CcSEcCtD
Enzalutamide—Diarrhoea—Ibandronate—osteoporosis	0.000315	0.00166	CcSEcCtD
Enzalutamide—Mental disorder—Estradiol—osteoporosis	0.000313	0.00165	CcSEcCtD
Enzalutamide—Dizziness—Alendronate—osteoporosis	0.000313	0.00165	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000312	0.00164	CcSEcCtD
Enzalutamide—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000311	0.00164	CcSEcCtD
Enzalutamide—Fatigue—Pamidronate—osteoporosis	0.000311	0.00164	CcSEcCtD
Enzalutamide—Diarrhoea—Calcitriol—osteoporosis	0.000309	0.00163	CcSEcCtD
Enzalutamide—Skin disorder—Conjugated Estrogens—osteoporosis	0.000308	0.00163	CcSEcCtD
Enzalutamide—Dizziness—Raloxifene—osteoporosis	0.000308	0.00162	CcSEcCtD
Enzalutamide—Dizziness—Ibandronate—osteoporosis	0.000305	0.00161	CcSEcCtD
Enzalutamide—Back pain—Estradiol—osteoporosis	0.000301	0.00159	CcSEcCtD
Enzalutamide—Headache—Estropipate—osteoporosis	0.000301	0.00159	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000301	0.00159	CcSEcCtD
Enzalutamide—Insomnia—Zoledronate—osteoporosis	0.000298	0.00157	CcSEcCtD
Enzalutamide—Headache—Alendronate—osteoporosis	0.000297	0.00156	CcSEcCtD
Enzalutamide—Paraesthesia—Zoledronate—osteoporosis	0.000296	0.00156	CcSEcCtD
Enzalutamide—Headache—Raloxifene—osteoporosis	0.000292	0.00154	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000289	0.00153	CcSEcCtD
Enzalutamide—Headache—Ibandronate—osteoporosis	0.000289	0.00152	CcSEcCtD
Enzalutamide—Insomnia—Conjugated Estrogens—osteoporosis	0.000287	0.00152	CcSEcCtD
Enzalutamide—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000285	0.0015	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000285	0.0015	CcSEcCtD
Enzalutamide—Fatigue—Zoledronate—osteoporosis	0.000284	0.0015	CcSEcCtD
Enzalutamide—Headache—Calcitriol—osteoporosis	0.000283	0.00149	CcSEcCtD
Enzalutamide—Vertigo—Estradiol—osteoporosis	0.00028	0.00148	CcSEcCtD
Enzalutamide—Asthenia—Ethinyl Estradiol—osteoporosis	0.00028	0.00147	CcSEcCtD
Enzalutamide—Pruritus—Ethinyl Estradiol—osteoporosis	0.000276	0.00145	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000274	0.00145	CcSEcCtD
Enzalutamide—Fatigue—Conjugated Estrogens—osteoporosis	0.000274	0.00144	CcSEcCtD
Enzalutamide—Asthenia—Risedronate—osteoporosis	0.000273	0.00144	CcSEcCtD
Enzalutamide—Hypertension—Estradiol—osteoporosis	0.000269	0.00142	CcSEcCtD
Enzalutamide—Pruritus—Risedronate—osteoporosis	0.000269	0.00142	CcSEcCtD
Enzalutamide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000267	0.00141	CcSEcCtD
Enzalutamide—Arthralgia—Estradiol—osteoporosis	0.000265	0.0014	CcSEcCtD
Enzalutamide—Anxiety—Estradiol—osteoporosis	0.000264	0.00139	CcSEcCtD
Enzalutamide—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000263	0.00139	CcSEcCtD
Enzalutamide—Diarrhoea—Risedronate—osteoporosis	0.00026	0.00137	CcSEcCtD
Enzalutamide—Asthenia—Pamidronate—osteoporosis	0.000259	0.00137	CcSEcCtD
Enzalutamide—Dizziness—Ethinyl Estradiol—osteoporosis	0.000258	0.00136	CcSEcCtD
Enzalutamide—Pruritus—Pamidronate—osteoporosis	0.000255	0.00135	CcSEcCtD
Enzalutamide—Infection—Estradiol—osteoporosis	0.000253	0.00133	CcSEcCtD
Enzalutamide—Dizziness—Risedronate—osteoporosis	0.000251	0.00133	CcSEcCtD
Enzalutamide—Nervous system disorder—Estradiol—osteoporosis	0.000249	0.00132	CcSEcCtD
Enzalutamide—Diarrhoea—Pamidronate—osteoporosis	0.000247	0.0013	CcSEcCtD
Enzalutamide—Skin disorder—Estradiol—osteoporosis	0.000247	0.0013	CcSEcCtD
Enzalutamide—Headache—Ethinyl Estradiol—osteoporosis	0.000244	0.00129	CcSEcCtD
Enzalutamide—Dizziness—Pamidronate—osteoporosis	0.000239	0.00126	CcSEcCtD
Enzalutamide—Headache—Risedronate—osteoporosis	0.000238	0.00126	CcSEcCtD
Enzalutamide—Asthenia—Zoledronate—osteoporosis	0.000237	0.00125	CcSEcCtD
Enzalutamide—Pruritus—Zoledronate—osteoporosis	0.000233	0.00123	CcSEcCtD
Enzalutamide—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000232	0.00122	CcSEcCtD
Enzalutamide—Insomnia—Estradiol—osteoporosis	0.00023	0.00121	CcSEcCtD
Enzalutamide—Paraesthesia—Estradiol—osteoporosis	0.000228	0.0012	CcSEcCtD
Enzalutamide—Asthenia—Conjugated Estrogens—osteoporosis	0.000228	0.0012	CcSEcCtD
Enzalutamide—Headache—Pamidronate—osteoporosis	0.000226	0.00119	CcSEcCtD
Enzalutamide—Diarrhoea—Zoledronate—osteoporosis	0.000226	0.00119	CcSEcCtD
Enzalutamide—Pruritus—Conjugated Estrogens—osteoporosis	0.000225	0.00119	CcSEcCtD
Enzalutamide—Gastrointestinal disorder—Estradiol—osteoporosis	0.000219	0.00116	CcSEcCtD
Enzalutamide—Fatigue—Estradiol—osteoporosis	0.000219	0.00116	CcSEcCtD
Enzalutamide—Dizziness—Zoledronate—osteoporosis	0.000218	0.00115	CcSEcCtD
Enzalutamide—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000217	0.00115	CcSEcCtD
Enzalutamide—Dizziness—Conjugated Estrogens—osteoporosis	0.00021	0.00111	CcSEcCtD
Enzalutamide—Headache—Zoledronate—osteoporosis	0.000207	0.00109	CcSEcCtD
Enzalutamide—Headache—Conjugated Estrogens—osteoporosis	0.000199	0.00105	CcSEcCtD
Enzalutamide—Asthenia—Estradiol—osteoporosis	0.000182	0.000962	CcSEcCtD
Enzalutamide—Pruritus—Estradiol—osteoporosis	0.00018	0.000949	CcSEcCtD
Enzalutamide—Diarrhoea—Estradiol—osteoporosis	0.000174	0.000918	CcSEcCtD
Enzalutamide—Dizziness—Estradiol—osteoporosis	0.000168	0.000887	CcSEcCtD
Enzalutamide—Headache—Estradiol—osteoporosis	0.000159	0.00084	CcSEcCtD
Enzalutamide—AR—Gene Expression—PSMA2—osteoporosis	3.39e-05	0.000875	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—PSMA5—osteoporosis	3.39e-05	0.000875	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PNP—osteoporosis	3.32e-05	0.000857	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ATIC—osteoporosis	3.32e-05	0.000857	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PKM—osteoporosis	3.31e-05	0.000856	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—FDPS—osteoporosis	3.31e-05	0.000856	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—FDPS—osteoporosis	3.29e-05	0.000851	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PKM—osteoporosis	3.29e-05	0.000851	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—TGFB1—osteoporosis	3.29e-05	0.00085	CbGpPWpGaD
Enzalutamide—ALB—Folate Metabolism—IL6—osteoporosis	3.27e-05	0.000844	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	3.24e-05	0.000838	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—TNF—osteoporosis	3.21e-05	0.000831	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GPD2—osteoporosis	3.14e-05	0.000811	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PGLS—osteoporosis	3.14e-05	0.000811	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	3.14e-05	0.00081	CbGpPWpGaD
Enzalutamide—CYP2C19—Biological oxidations—POMC—osteoporosis	3.14e-05	0.00081	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—FGB—osteoporosis	3.13e-05	0.000809	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	3.13e-05	0.000808	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PGLS—osteoporosis	3.12e-05	0.000807	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GPD2—osteoporosis	3.12e-05	0.000807	CbGpPWpGaD
Enzalutamide—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	3.09e-05	0.000799	CbGpPWpGaD
Enzalutamide—ABCB1—Allograft Rejection—TNF—osteoporosis	3.07e-05	0.000793	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—ESR2—osteoporosis	3.03e-05	0.000782	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PKM—osteoporosis	2.96e-05	0.000764	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—FDPS—osteoporosis	2.96e-05	0.000764	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	2.96e-05	0.000764	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PKM—osteoporosis	2.89e-05	0.000746	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—FDPS—osteoporosis	2.89e-05	0.000746	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CA2—osteoporosis	2.88e-05	0.000745	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—OXCT1—osteoporosis	2.88e-05	0.000745	CbGpPWpGaD
Enzalutamide—CYP2D6—Biological oxidations—POMC—osteoporosis	2.88e-05	0.000745	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ATIC—osteoporosis	2.87e-05	0.000742	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PNP—osteoporosis	2.87e-05	0.000742	CbGpPWpGaD
Enzalutamide—CYP2C9—Biological oxidations—POMC—osteoporosis	2.86e-05	0.000739	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PNP—osteoporosis	2.86e-05	0.000738	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ATIC—osteoporosis	2.86e-05	0.000738	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CA2—osteoporosis	2.82e-05	0.000728	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—OXCT1—osteoporosis	2.82e-05	0.000728	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—MGLL—osteoporosis	2.81e-05	0.000726	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GPD2—osteoporosis	2.8e-05	0.000724	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PGLS—osteoporosis	2.8e-05	0.000724	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	2.75e-05	0.00071	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—MGLL—osteoporosis	2.75e-05	0.00071	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GPD2—osteoporosis	2.74e-05	0.000707	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PGLS—osteoporosis	2.74e-05	0.000707	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PKM—osteoporosis	2.72e-05	0.000703	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—FDPS—osteoporosis	2.72e-05	0.000703	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	2.71e-05	0.000699	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—FDPS—osteoporosis	2.7e-05	0.000697	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PKM—osteoporosis	2.7e-05	0.000697	CbGpPWpGaD
Enzalutamide—ALB—Selenium Micronutrient Network—IL6—osteoporosis	2.59e-05	0.00067	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GPD2—osteoporosis	2.58e-05	0.000666	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PGLS—osteoporosis	2.58e-05	0.000666	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ATIC—osteoporosis	2.56e-05	0.000662	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PNP—osteoporosis	2.56e-05	0.000662	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PGLS—osteoporosis	2.56e-05	0.00066	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GPD2—osteoporosis	2.56e-05	0.00066	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ATIC—osteoporosis	2.5e-05	0.000646	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PNP—osteoporosis	2.5e-05	0.000646	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CA2—osteoporosis	2.44e-05	0.000631	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—OXCT1—osteoporosis	2.44e-05	0.000631	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CA2—osteoporosis	2.43e-05	0.000627	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—OXCT1—osteoporosis	2.43e-05	0.000627	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—VDR—osteoporosis	2.4e-05	0.00062	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—IDH2—osteoporosis	2.39e-05	0.000618	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—MGLL—osteoporosis	2.38e-05	0.000615	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—MGLL—osteoporosis	2.37e-05	0.000611	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PNP—osteoporosis	2.36e-05	0.000609	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ATIC—osteoporosis	2.36e-05	0.000609	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ATIC—osteoporosis	2.34e-05	0.000604	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PNP—osteoporosis	2.34e-05	0.000604	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—IDH2—osteoporosis	2.34e-05	0.000604	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYP27A1—osteoporosis	2.25e-05	0.000581	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.24e-05	0.00058	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.23e-05	0.000577	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP27A1—osteoporosis	2.2e-05	0.000568	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ACP5—osteoporosis	2.19e-05	0.000565	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—OXCT1—osteoporosis	2.18e-05	0.000563	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CA2—osteoporosis	2.18e-05	0.000563	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ACP5—osteoporosis	2.14e-05	0.000552	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—OXCT1—osteoporosis	2.13e-05	0.00055	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CA2—osteoporosis	2.13e-05	0.00055	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—MGLL—osteoporosis	2.12e-05	0.000549	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—MGLL—osteoporosis	2.07e-05	0.000536	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—TPI1—osteoporosis	2.03e-05	0.000525	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—IDH2—osteoporosis	2.02e-05	0.000523	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—IDH2—osteoporosis	2.01e-05	0.00052	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CA2—osteoporosis	2.01e-05	0.000518	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—OXCT1—osteoporosis	2.01e-05	0.000518	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2e-05	0.000518	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—OXCT1—osteoporosis	1.99e-05	0.000514	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CA2—osteoporosis	1.99e-05	0.000514	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—TPI1—osteoporosis	1.99e-05	0.000513	CbGpPWpGaD
Enzalutamide—AR—Generic Transcription Pathway—MYC—osteoporosis	1.98e-05	0.000512	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—MGLL—osteoporosis	1.95e-05	0.000505	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—MGLL—osteoporosis	1.94e-05	0.0005	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—P4HB—osteoporosis	1.91e-05	0.000494	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP27A1—osteoporosis	1.9e-05	0.000492	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP27A1—osteoporosis	1.89e-05	0.000489	CbGpPWpGaD
Enzalutamide—CYP3A4—Biological oxidations—POMC—osteoporosis	1.89e-05	0.000487	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GAPDH—osteoporosis	1.88e-05	0.000485	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—P4HB—osteoporosis	1.87e-05	0.000483	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ACP5—osteoporosis	1.85e-05	0.000478	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ACP5—osteoporosis	1.84e-05	0.000475	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—ESR1—osteoporosis	1.84e-05	0.000474	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GAPDH—osteoporosis	1.83e-05	0.000474	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.83e-05	0.000472	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—RAP1A—osteoporosis	1.83e-05	0.000472	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.83e-05	0.000472	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.82e-05	0.000469	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—IDH2—osteoporosis	1.81e-05	0.000467	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—RAP1A—osteoporosis	1.79e-05	0.000461	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—FDPS—osteoporosis	1.78e-05	0.000459	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PKM—osteoporosis	1.78e-05	0.000459	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—IDH2—osteoporosis	1.76e-05	0.000455	CbGpPWpGaD
Enzalutamide—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.73e-05	0.000448	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—TPI1—osteoporosis	1.72e-05	0.000445	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—TPI1—osteoporosis	1.71e-05	0.000442	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP27A1—osteoporosis	1.7e-05	0.000439	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PGLS—osteoporosis	1.69e-05	0.000435	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GPD2—osteoporosis	1.69e-05	0.000435	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—IDH2—osteoporosis	1.66e-05	0.000429	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP27A1—osteoporosis	1.66e-05	0.000428	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ACP5—osteoporosis	1.65e-05	0.000427	CbGpPWpGaD
Enzalutamide—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	1.65e-05	0.000426	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—IDH2—osteoporosis	1.65e-05	0.000426	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.63e-05	0.000421	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.63e-05	0.00042	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.62e-05	0.000419	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—P4HB—osteoporosis	1.62e-05	0.000418	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ACP5—osteoporosis	1.61e-05	0.000417	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—P4HB—osteoporosis	1.61e-05	0.000416	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GAPDH—osteoporosis	1.59e-05	0.00041	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GAPDH—osteoporosis	1.58e-05	0.000408	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP27A1—osteoporosis	1.56e-05	0.000404	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP27A1—osteoporosis	1.55e-05	0.0004	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—RAP1A—osteoporosis	1.55e-05	0.0004	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ATIC—osteoporosis	1.54e-05	0.000398	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PNP—osteoporosis	1.54e-05	0.000398	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—RAP1A—osteoporosis	1.54e-05	0.000397	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—TPI1—osteoporosis	1.54e-05	0.000397	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ACP5—osteoporosis	1.52e-05	0.000393	CbGpPWpGaD
Enzalutamide—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.52e-05	0.000392	CbGpPWpGaD
Enzalutamide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.52e-05	0.000391	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ACP5—osteoporosis	1.51e-05	0.000389	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—TPI1—osteoporosis	1.5e-05	0.000387	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	1.49e-05	0.000384	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ENO1—osteoporosis	1.48e-05	0.000382	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PSMA2—osteoporosis	1.46e-05	0.000376	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—PSMA5—osteoporosis	1.46e-05	0.000376	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—P4HB—osteoporosis	1.44e-05	0.000373	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ENO1—osteoporosis	1.44e-05	0.000373	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PSMA5—osteoporosis	1.42e-05	0.000367	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—PSMA2—osteoporosis	1.42e-05	0.000367	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GAPDH—osteoporosis	1.42e-05	0.000366	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—IGF1—osteoporosis	1.42e-05	0.000366	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—TPI1—osteoporosis	1.41e-05	0.000365	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—P4HB—osteoporosis	1.41e-05	0.000364	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—TPI1—osteoporosis	1.4e-05	0.000362	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GAPDH—osteoporosis	1.38e-05	0.000357	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—RAP1A—osteoporosis	1.38e-05	0.000357	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.35e-05	0.000348	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—RAP1A—osteoporosis	1.35e-05	0.000348	CbGpPWpGaD
Enzalutamide—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.34e-05	0.000346	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—P4HB—osteoporosis	1.33e-05	0.000343	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—P4HB—osteoporosis	1.32e-05	0.00034	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CA2—osteoporosis	1.31e-05	0.000339	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—OXCT1—osteoporosis	1.31e-05	0.000339	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GAPDH—osteoporosis	1.3e-05	0.000337	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GAPDH—osteoporosis	1.29e-05	0.000334	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—MGLL—osteoporosis	1.28e-05	0.00033	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—RAP1A—osteoporosis	1.27e-05	0.000328	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—RAP1A—osteoporosis	1.26e-05	0.000325	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ENO1—osteoporosis	1.25e-05	0.000323	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ENO1—osteoporosis	1.24e-05	0.000321	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PSMA2—osteoporosis	1.23e-05	0.000318	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—PSMA5—osteoporosis	1.23e-05	0.000318	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PSMA2—osteoporosis	1.22e-05	0.000316	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—PSMA5—osteoporosis	1.22e-05	0.000316	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.2e-05	0.000311	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—CYP19A1—osteoporosis	1.18e-05	0.000305	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—CYP19A1—osteoporosis	1.15e-05	0.000298	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ENO1—osteoporosis	1.12e-05	0.000288	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PSMA2—osteoporosis	1.1e-05	0.000284	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—PSMA5—osteoporosis	1.1e-05	0.000284	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.1e-05	0.000284	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ENO1—osteoporosis	1.09e-05	0.000281	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—IDH2—osteoporosis	1.09e-05	0.000281	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PSMA2—osteoporosis	1.07e-05	0.000277	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—PSMA5—osteoporosis	1.07e-05	0.000277	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ENO1—osteoporosis	1.03e-05	0.000265	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP27A1—osteoporosis	1.02e-05	0.000264	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ENO1—osteoporosis	1.02e-05	0.000263	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PSMA2—osteoporosis	1.01e-05	0.000261	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—PSMA5—osteoporosis	1.01e-05	0.000261	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PSMA2—osteoporosis	1e-05	0.000259	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—PSMA5—osteoporosis	1e-05	0.000259	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—CYP19A1—osteoporosis	1e-05	0.000258	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—CYP19A1—osteoporosis	9.94e-06	0.000257	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ACP5—osteoporosis	9.93e-06	0.000257	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—ADCY5—osteoporosis	9.65e-06	0.000249	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—GPX1—osteoporosis	9.61e-06	0.000248	CbGpPWpGaD
Enzalutamide—AR—Gene Expression—MYC—osteoporosis	9.55e-06	0.000247	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—ADCY5—osteoporosis	9.43e-06	0.000244	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—GPX1—osteoporosis	9.4e-06	0.000243	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—TPI1—osteoporosis	9.24e-06	0.000239	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—CYP19A1—osteoporosis	8.92e-06	0.00023	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—MTHFR—osteoporosis	8.87e-06	0.000229	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—CYP19A1—osteoporosis	8.71e-06	0.000225	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—P4HB—osteoporosis	8.68e-06	0.000224	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—MTHFR—osteoporosis	8.67e-06	0.000224	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GAPDH—osteoporosis	8.52e-06	0.00022	CbGpPWpGaD
Enzalutamide—ALB—Hemostasis—TGFB1—osteoporosis	8.49e-06	0.000219	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—RAP1A—osteoporosis	8.3e-06	0.000214	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—CYP19A1—osteoporosis	8.21e-06	0.000212	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—ADCY5—osteoporosis	8.17e-06	0.000211	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—GPX1—osteoporosis	8.14e-06	0.00021	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—CYP19A1—osteoporosis	8.13e-06	0.00021	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—ADCY5—osteoporosis	8.12e-06	0.00021	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—GPX1—osteoporosis	8.09e-06	0.000209	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—MTHFR—osteoporosis	7.51e-06	0.000194	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—MTHFR—osteoporosis	7.47e-06	0.000193	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—ADCY5—osteoporosis	7.29e-06	0.000188	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—GPX1—osteoporosis	7.26e-06	0.000188	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—ADCY5—osteoporosis	7.11e-06	0.000184	CbGpPWpGaD
Enzalutamide—CYP2B6—Metabolism—POMC—osteoporosis	7.1e-06	0.000183	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—GPX1—osteoporosis	7.09e-06	0.000183	CbGpPWpGaD
Enzalutamide—CYP3A5—Metabolism—POMC—osteoporosis	6.94e-06	0.000179	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ENO1—osteoporosis	6.71e-06	0.000173	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—ADCY5—osteoporosis	6.7e-06	0.000173	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—MTHFR—osteoporosis	6.7e-06	0.000173	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—GPX1—osteoporosis	6.68e-06	0.000173	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—ADCY5—osteoporosis	6.65e-06	0.000172	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—GPX1—osteoporosis	6.62e-06	0.000171	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PSMA2—osteoporosis	6.61e-06	0.000171	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—PSMA5—osteoporosis	6.61e-06	0.000171	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—MTHFR—osteoporosis	6.54e-06	0.000169	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—MTHFR—osteoporosis	6.17e-06	0.000159	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—MTHFR—osteoporosis	6.11e-06	0.000158	CbGpPWpGaD
Enzalutamide—CYP2C8—Metabolism—POMC—osteoporosis	6.01e-06	0.000155	CbGpPWpGaD
Enzalutamide—ALB—Metabolism—POMC—osteoporosis	5.97e-06	0.000154	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—CYP19A1—osteoporosis	5.36e-06	0.000139	CbGpPWpGaD
Enzalutamide—CYP2C19—Metabolism—POMC—osteoporosis	5.36e-06	0.000139	CbGpPWpGaD
Enzalutamide—ABCB1—Metabolism—POMC—osteoporosis	5.23e-06	0.000135	CbGpPWpGaD
Enzalutamide—CYP2D6—Metabolism—POMC—osteoporosis	4.93e-06	0.000127	CbGpPWpGaD
Enzalutamide—CYP2C9—Metabolism—POMC—osteoporosis	4.89e-06	0.000126	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—ADCY5—osteoporosis	4.38e-06	0.000113	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—GPX1—osteoporosis	4.37e-06	0.000113	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—MTHFR—osteoporosis	4.03e-06	0.000104	CbGpPWpGaD
Enzalutamide—CYP3A4—Metabolism—POMC—osteoporosis	3.22e-06	8.33e-05	CbGpPWpGaD
